Changes in Optical Coherence Tomography Leakage Mapping in Diabetic Macular Edema After Conbercept Treatment

Summary

Participation Requirements

Description

Research purpose: After one month follow-up, we will observe whether OCTleakage mapping can be used as a biomarker to predict the prognosis of DME eyes, and will observe the effect of Conbercept on improving edema and visual acuity of DME eyes. Subjects Number of subjects planned to be recruited: 35...

Research purpose: After one month follow-up, we will observe whether OCTleakage mapping can be used as a biomarker to predict the prognosis of DME eyes, and will observe the effect of Conbercept on improving edema and visual acuity of DME eyes. Subjects Number of subjects planned to be recruited: 35 Inclusion criteria: Age ? 18 Diabetic macular edema eyes treated with conbercept for the first time in 1 week Informed consent of patients and signing of informed consent Exclusion criteria: High myopia Macular diseases affecting vision Vitreous hemorrhage requiring surgery Patients with anterior segment neovascularization Eye or periocular infection Optic neuropathy and glaucoma Periphlebitis, ophthalmic ischemic syndrome, uveitis, coat's disease, FEVR and other retinal diseases Ametropia and cataract surgery In 3 months, in addition to this treatment of conbercept, other anti VEGF treatment, laser treatment or vitreoretinal surgery were performed Other systemic diseases can not complete follow-up

Tracking Information